Title : Fas-mediated modulation of Bcr/Abl in chronic myelogenous leukemia results in differential effects on apoptosis.

Pub. Date : 1998 Aug 1

PMID : 9680367






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 After priming with IFN-alpha, Fas triggering resulted in in vitro suppression of hematopoietic cell growth in seven of eight patients who had optimal hematologic response to IFN-alpha; in the same conditions, no inhibitory response to Fas-R agonist was observed in cells from three of three patients who proved to be poor responders to IFN-alpha. ammonium ferrous sulfate interferon alpha 1 Homo sapiens
2 After priming with IFN-alpha, Fas triggering resulted in in vitro suppression of hematopoietic cell growth in seven of eight patients who had optimal hematologic response to IFN-alpha; in the same conditions, no inhibitory response to Fas-R agonist was observed in cells from three of three patients who proved to be poor responders to IFN-alpha. ammonium ferrous sulfate interferon alpha 1 Homo sapiens
3 It appears that Fas-mediated downmodulation of p210 bcr/abl restores susceptibility to apoptosis of CML cells; in addition, in vitro studies on CML cells may predict response to IFN-alpha treatment. ammonium ferrous sulfate interferon alpha 1 Homo sapiens